Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

As pandemic eases, many seniors have lost strength, may need rehabilitative services

Ronald Lindquist, 87, has been active all his life. So, he wasn't prepared for what happened when he stopped going out during the coronavirus pandemic and spent most of his time, inactive, at home.

21 May 2021

Masks and physical distancing could reduce SARS-CoV-2 spread to 1% among essential food plant workers, says study

The food supply is an essential service. Yet, workers in this industry are at high risk of acquiring infection with the novel coronavirus in their workplace unless proper mitigation measures are put in place. A new study, released as a preprint on the medRxiv* server, shows that the risk of infection may be reduced to less than 1% with proper precautions.

21 May 2021

Facets of SARS-CoV-2 infection and animal models

A new study in the journal Frontiers in Cell and Developmental Biology discusses the ribonucleic acid (RNA) genome of the virus, and the mechanisms by which it establishes infection within the host cell. The researchers also summarize the development of animal models of COVID-19, which will both help understand the clinical features of the illness, and indicate new approaches for the treatment of the infection.

21 May 2021

Researchers evaluate risk of developing new clinical conditions after acute phase of COVID-19 infection

One in 7 (14%) adults with coronavirus infection developed at least one new condition that required medical care during the post-acute phase of illness, which is 5% higher than adults with no coronavirus infection in 2020, finds a US study published by The BMJ today.

21 May 2021

Despite frequent vaccinations, COVID-19 could continue to cause recurrent waves and deaths

Covid-19 could continue to cause recurrent waves and deaths despite frequent vaccinations according to a new study from the University of East Anglia.

21 May 2021

Study analyzes the risk of other medical conditions after recovery from COVID-19

Researchers analyzed data from a large insurance company in the United States. They found an increased risk of other medical conditions after recovering from COVID-19 irrespective of pre-existing conditions or age.

21 May 2021

Metal complexes against coronavirus

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 3.42 million deaths worldwide. Despite the fact that there are vaccines for SARS-CoV-2, the emergence of new variants and the lack of adequate treatments have encouraged the search for new ways to combat this disease more effectively.

21 May 2021

Study shows distinctive mutation in rapidly emerging SARS-CoV-2 B.1.1.7 sublineage

In a new study currently available on the medRxiv* preprint server, US researchers report the detection of a specific sub-lineage of B.1.1.7 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant harboring a novel S:D178H mutation and elucidate its transmission and evolutionary patterns.

21 May 2021

Total COVID-19 deaths in US counties have been underestimated by 20%, indicates study

Deaths caused by indirect effects of the pandemic emphasize the need for policy changes that address widening health and racial inequities.

21 May 2021

SARS-CoV-2 spike mutation can independently predict viral evolution

A team of scientists from Portugal has recently estimated the rate of mutation in two circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using experimental evolution methods. Their findings reveal that in a condition with no immune surveillance, SARS-CoV-2 can potentially undergo evolution during the first stages of infection. The study is currently available on the bioRxiv* preprint server.

21 May 2021

Researchers discover new coronavirus in East Malaysia

Researchers have discovered a new coronavirus, found in a child with pneumonia in Malaysia in 2018, that appears to have jumped from dog to human.

21 May 2021

Researchers define immune determinants of protection against SARS-CoV-2 in mice

Researchers in the United States have conducted a preclinical study defining the roles that different arms of the immune system play in fighting primary infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as reinfection and infection following SARS-CoV-2 vaccination.

21 May 2021

Pfizer-BioNTech and Sinovac vaccines boost SARS-CoV-2 neutralizing responses

Researchers in the United States and Chile have provided preliminary evidence that individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – mount a robust neutralizing antibody response against the virus that can be significantly boosted by two doses of Sinovac Biotech’s CoronaVac vaccine or one dose of Pfizer-BioNTech’s BNT162b2 vaccine.

21 May 2021

North America has 87% of all unique SARS-CoV-2 S protein variants in the NCBI database among six continents

Recently, a team of researchers from various countries analyzed the unique variants of S proteins across six continents, including Africa, Asia, Oceania, Europe, South America, and North America. They wanted to characterize the unique S protein variants embedded in SARS-CoV-2 genomes infecting millions of people globally.

20 May 2021

Swiss study suggests very low prevalence of long COVID in pediatric population

Researchers from Switzerland recently analyzed long COVID symptoms in children and adolescents with a 6-month follow-up based on their SARS-CoV-2 serology. A longitudinal cohort analysis, the Ciao Corona study investigated SARS-CoV-2 seroprevalence and case clustering among ~2500 children from 55 primary and secondary schools in Zurich, Switzerland.

20 May 2021

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Researchers from the US and Denmark recently described a novel therapeutic option that targets the SARS-CoV-2 ribonucleic acid (RNA) using locked nucleic acid antisense oligonucleotides (LNA ASOs). They identified an LNA ASO that binds to the 5’ leader sequence of SARS-CoV-2 ORF1a/b. This disrupts a highly conserved stem-loop structure with nanomolar efficacy and inhibits viral replication in host cells.

20 May 2021

Researchers speculate the low prevalence of COVID-19 in Japan

Protective immune memory--through B cells, which make antibodies, and/or T cells, which in the case of CD8+ T cells can kill virus-infected cells--can be induced by identical but also by related viruses.

20 May 2021

Resuming global childhood vaccination campaigns during the COVID-19 pandemic

New research published on the medRxiv* preprint server suggests childhood vaccination to prevent other infectious diseases has plummeted during the pandemic. The decrease appears to stem from the suspension of health campaigns promoting immunization and the risk of catching the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).

20 May 2021

COVID-19 cases in summer 2020 was not as low as previously thought, new genome-based model suggests

Many have attributed the low number of coronavirus disease 2019 (COVID-19) cases in the summer of 2020 to hot weather or increased outdoor activities. But a new study from researchers in Germany suggests this might not have been the case.

20 May 2021

How is COVID-19 changing hunting patterns during lockdown in India?

To examine the real impact of COVID-19 lockdown on wildlife hunting across India, a team of researchers conducted a study from March-May 2020. Using media reports and online interviews with wildlife researchers, enforcement staff and NGO employees, the research team explored the change in hunting patterns and the socio-economic and institutional factors underlying these changes.

20 May 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

As pandemic eases, many seniors have lost strength, may need rehabilitative services

Masks and physical distancing could reduce SARS-CoV-2 spread to 1% among essential food plant workers, says study

Facets of SARS-CoV-2 infection and animal models

Researchers evaluate risk of developing new clinical conditions after acute phase of COVID-19 infection

Despite frequent vaccinations, COVID-19 could continue to cause recurrent waves and deaths

Study analyzes the risk of other medical conditions after recovery from COVID-19

Metal complexes against coronavirus

Study shows distinctive mutation in rapidly emerging SARS-CoV-2 B.1.1.7 sublineage

Total COVID-19 deaths in US counties have been underestimated by 20%, indicates study

SARS-CoV-2 spike mutation can independently predict viral evolution

Researchers discover new coronavirus in East Malaysia

Researchers define immune determinants of protection against SARS-CoV-2 in mice

Pfizer-BioNTech and Sinovac vaccines boost SARS-CoV-2 neutralizing responses

North America has 87% of all unique SARS-CoV-2 S protein variants in the NCBI database among six continents

Swiss study suggests very low prevalence of long COVID in pediatric population

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Researchers speculate the low prevalence of COVID-19 in Japan

Resuming global childhood vaccination campaigns during the COVID-19 pandemic

COVID-19 cases in summer 2020 was not as low as previously thought, new genome-based model suggests

How is COVID-19 changing hunting patterns during lockdown in India?

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in